Solazyme CTO Unloads $77,700 in Stock (SZYM)
Solazyme (NASDAQ:SZYM) CTO Peter Licari sold 7,000 shares of Solazyme stock on the open market in a transaction dated Thursday, October 10th. The shares were sold at an average price of $11.10, for a total value of $77,700.00. Following the completion of the sale, the chief technology officer now directly owns 253,716 shares of the company’s stock, valued at approximately $2,816,248. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
A number of research firms have recently commented on SZYM. Analysts at Goldman Sachs Group Inc. reiterated a “buy” rating on shares of Solazyme in a research note to investors on Wednesday, September 25th. They now have a $14.00 price target on the stock. Analysts at Robert W. Baird raised their price target on shares of Solazyme from $12.00 to $16.00 in a research note to investors on Thursday, August 8th. They now have an “outperform” rating on the stock. One equities research analyst has rated the stock with a sell rating and seven have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $13.50.
Shares of Solazyme (NASDAQ:SZYM) traded up 4.19% during mid-day trading on Thursday, hitting $11.43. The stock had a trading volume of 472,191 shares. Solazyme has a 52-week low of $6.45 and a 52-week high of $13.09. The stock has a 50-day moving average of $11.06 and a 200-day moving average of $10.63. The company’s market cap is $712.2 million.
Solazyme (NASDAQ:SZYM) last issued its quarterly earnings data on Wednesday, August 7th. The company reported ($0.28) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.40) by $0.12. The company had revenue of $11.20 million for the quarter, compared to the consensus estimate of $10.66 million. During the same quarter in the prior year, the company posted ($0.27) earnings per share. The company’s quarterly revenue was down 17.0% on a year-over-year basis. Analysts expect that Solazyme will post $-1.59 EPS for the current fiscal year.
Solazyme, Inc operates as a renewable oil production company. The Company fuels include microbial-derived jet fuels, bio-diesels, and renewable diesels.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.